Covid19
Covid-19: Zydus seeks DCGI nod to undertake clinical trials for monoclonal antibodies cocktail
Zydus has announced biological therapy ZRC-3308, used to treat mild COVID-19. The pharmaceutical company now seeks DCGI (Drugs Controller …
Zydus has announced biological therapy ZRC-3308, used to treat mild COVID-19. The pharmaceutical company now seeks DCGI (Drugs Controller …
